MX2007013110A - Metodos y dispositivos para aliviar el estres. - Google Patents
Metodos y dispositivos para aliviar el estres.Info
- Publication number
- MX2007013110A MX2007013110A MX2007013110A MX2007013110A MX2007013110A MX 2007013110 A MX2007013110 A MX 2007013110A MX 2007013110 A MX2007013110 A MX 2007013110A MX 2007013110 A MX2007013110 A MX 2007013110A MX 2007013110 A MX2007013110 A MX 2007013110A
- Authority
- MX
- Mexico
- Prior art keywords
- wave
- point
- exemplary
- breathing
- flow continues
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 534
- 230000029058 respiratory gaseous exchange Effects 0.000 claims abstract description 134
- 230000001734 parasympathetic effect Effects 0.000 claims abstract description 75
- 230000008569 process Effects 0.000 claims description 379
- 210000003811 finger Anatomy 0.000 claims description 34
- 230000006870 function Effects 0.000 claims description 21
- 230000000007 visual effect Effects 0.000 claims description 13
- 230000033764 rhythmic process Effects 0.000 claims description 9
- 210000003813 thumb Anatomy 0.000 claims description 3
- 238000012800 visualization Methods 0.000 claims description 3
- 230000004308 accommodation Effects 0.000 claims 1
- 230000035882 stress Effects 0.000 description 72
- 230000001020 rhythmical effect Effects 0.000 description 34
- 230000007704 transition Effects 0.000 description 26
- 230000008859 change Effects 0.000 description 24
- 238000012937 correction Methods 0.000 description 23
- 238000001514 detection method Methods 0.000 description 22
- 230000007423 decrease Effects 0.000 description 20
- 230000010355 oscillation Effects 0.000 description 17
- 230000004044 response Effects 0.000 description 17
- 238000012360 testing method Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- 230000001788 irregular Effects 0.000 description 10
- 230000002889 sympathetic effect Effects 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 230000001174 ascending effect Effects 0.000 description 8
- 230000007774 longterm Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 238000013459 approach Methods 0.000 description 7
- 230000006399 behavior Effects 0.000 description 7
- 230000000241 respiratory effect Effects 0.000 description 7
- 230000003938 response to stress Effects 0.000 description 7
- 208000035475 disorder Diseases 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 230000002269 spontaneous effect Effects 0.000 description 6
- 230000006793 arrhythmia Effects 0.000 description 5
- 206010003119 arrhythmia Diseases 0.000 description 5
- 210000003403 autonomic nervous system Anatomy 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 238000007726 management method Methods 0.000 description 5
- 230000002459 sustained effect Effects 0.000 description 5
- 238000012549 training Methods 0.000 description 5
- 230000002763 arrhythmic effect Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 230000003340 mental effect Effects 0.000 description 4
- 230000035790 physiological processes and functions Effects 0.000 description 4
- 208000003443 Unconsciousness Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000012550 audit Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000035565 breathing frequency Effects 0.000 description 3
- 230000037326 chronic stress Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000000750 endocrine system Anatomy 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 206010012335 Dependence Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 230000004179 hypothalamic–pituitary–adrenal axis Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000011458 pharmacological treatment Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000036387 respiratory rate Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- NTMYVTSWQJFCPA-UHFFFAOYSA-N (2-tert-butylpyrimidin-5-yl)oxy-ethoxy-propan-2-yloxy-sulfanylidene-$l^{5}-phosphane;[cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CCOP(=S)(OC(C)C)OC1=CN=C(C(C)(C)C)N=C1.CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 NTMYVTSWQJFCPA-UHFFFAOYSA-N 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000013200 Stress disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000003372 endocrine gland Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000005057 finger movement Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- ZEKANFGSDXODPD-UHFFFAOYSA-N glyphosate-isopropylammonium Chemical compound CC(C)N.OC(=O)CNCP(O)(O)=O ZEKANFGSDXODPD-UHFFFAOYSA-N 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000007620 mathematical function Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008035 nerve activity Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000013186 photoplethysmography Methods 0.000 description 1
- 230000009894 physiological stress Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000012066 statistical methodology Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62B—DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING
- A62B7/00—Respiratory apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/486—Bio-feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4029—Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
- A61B5/4035—Evaluating the autonomic nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Business, Economics & Management (AREA)
- Emergency Management (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67314805P | 2005-04-20 | 2005-04-20 | |
| US67362705P | 2005-04-21 | 2005-04-21 | |
| US70588305P | 2005-08-04 | 2005-08-04 | |
| PCT/US2006/015013 WO2006113900A2 (en) | 2005-04-20 | 2006-04-20 | Methods and devices for relieving stress |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007013110A true MX2007013110A (es) | 2008-02-19 |
Family
ID=37115960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007013110A MX2007013110A (es) | 2005-04-20 | 2006-04-20 | Metodos y dispositivos para aliviar el estres. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1874186A4 (ja) |
| JP (1) | JP2008536648A (ja) |
| KR (1) | KR101303354B1 (ja) |
| AU (1) | AU2006236216A1 (ja) |
| BR (1) | BRPI0610848A2 (ja) |
| CA (1) | CA2604741C (ja) |
| MX (1) | MX2007013110A (ja) |
| WO (1) | WO2006113900A2 (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3967219A1 (en) * | 2006-11-01 | 2022-03-16 | ResMed Sensor Technologies Limited | System and method for monitoring cardiorespiratory parameters |
| JP5173251B2 (ja) * | 2007-05-11 | 2013-04-03 | テルモ株式会社 | 拍動ゆらぎ測定装置およびその情報処理方法 |
| DE102008030956B4 (de) | 2007-10-16 | 2010-01-07 | Biosign Gmbh | Gerät zur Messung der Herzratenvariabilität |
| JP5315948B2 (ja) * | 2008-11-19 | 2013-10-16 | 富士通株式会社 | 脈拍数算出プログラム、脈拍数算出装置、脈拍数算出方法および携帯端末装置 |
| DE102008061997A1 (de) | 2008-12-12 | 2010-06-17 | Karlsruher Institut für Technologie | System und Verfahren zum Stresstraining eines Benutzers |
| JP2013128659A (ja) * | 2011-12-21 | 2013-07-04 | Pacific Medico Co Ltd | 携帯式呼吸誘導装置 |
| US9339193B2 (en) * | 2012-05-21 | 2016-05-17 | Fujitsu Limited | Physiological adaptability system with multiple sensors |
| JP6479720B2 (ja) * | 2016-08-30 | 2019-03-06 | 株式会社電通 | 瞑想補助装置および瞑想補助システム |
| JP6476334B2 (ja) * | 2018-05-29 | 2019-02-27 | 株式会社電通 | 瞑想補助装置および瞑想補助システム |
| KR102352629B1 (ko) * | 2020-05-19 | 2022-01-18 | 성균관대학교산학협력단 | 피부 영상의 호흡 신호를 이용한 스트레스 지수 측정 및 관리 방법 및 장치 |
| US20220361759A1 (en) | 2021-05-04 | 2022-11-17 | Koa Health B.V. | Smartphone Heart Rate And Breathing Rate Determination Using Accuracy Measurement Weighting |
| WO2023234840A1 (en) * | 2022-06-02 | 2023-12-07 | Linkura Ab | A method, software product, and system for determining respiration quality |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5129401A (en) * | 1986-10-17 | 1992-07-14 | Nellcor, Inc. | Method for distinguishing respiratory events in a gas analyzer |
| US6305943B1 (en) | 1999-01-29 | 2001-10-23 | Biomed Usa, Inc. | Respiratory sinus arrhythmia training system |
| IL130818A (en) | 1999-07-06 | 2005-07-25 | Intercure Ltd | Interventive-diagnostic device |
| US6626843B2 (en) * | 2001-09-28 | 2003-09-30 | Deane Hillsman | Respiratory timing and lung deflation method and device |
| AU2003217564A1 (en) * | 2002-02-22 | 2003-09-09 | Datex-Ohmeda, Inc. | Monitoring physiological parameters based on variations in a photoplethysmographic signal |
| US6684626B1 (en) | 2002-07-30 | 2004-02-03 | General Electric Company | Aircraft gas turbine engine with control vanes for counter rotating low pressure turbines |
| CA2560294C (en) * | 2004-03-18 | 2014-05-27 | Helicor Inc. | Methods and devices for relieving stress |
-
2006
- 2006-04-20 BR BRPI0610848-2A patent/BRPI0610848A2/pt not_active IP Right Cessation
- 2006-04-20 JP JP2008507896A patent/JP2008536648A/ja active Pending
- 2006-04-20 WO PCT/US2006/015013 patent/WO2006113900A2/en active Application Filing
- 2006-04-20 CA CA2604741A patent/CA2604741C/en not_active Expired - Fee Related
- 2006-04-20 MX MX2007013110A patent/MX2007013110A/es not_active Application Discontinuation
- 2006-04-20 KR KR1020077026989A patent/KR101303354B1/ko active IP Right Grant
- 2006-04-20 AU AU2006236216A patent/AU2006236216A1/en not_active Abandoned
- 2006-04-20 EP EP06750906.7A patent/EP1874186A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006113900A8 (en) | 2008-01-31 |
| EP1874186A2 (en) | 2008-01-09 |
| WO2006113900A2 (en) | 2006-10-26 |
| EP1874186A4 (en) | 2013-08-21 |
| BRPI0610848A2 (pt) | 2010-08-03 |
| CA2604741C (en) | 2014-11-25 |
| AU2006236216A1 (en) | 2006-10-26 |
| KR20080011294A (ko) | 2008-02-01 |
| JP2008536648A (ja) | 2008-09-11 |
| WO2006113900A3 (en) | 2007-11-15 |
| KR101303354B1 (ko) | 2013-09-03 |
| CA2604741A1 (en) | 2006-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8428702B2 (en) | Methods and devices for relieving stress | |
| CA2560294C (en) | Methods and devices for relieving stress | |
| CA2604741C (en) | Methods and devices for relieving stress | |
| US8666482B2 (en) | Method, system and software product for the measurement of heart rate variability | |
| CN107427267B (zh) | 用于导出主体的精神状态的方法和装置 | |
| US8515551B2 (en) | Diagnostic method and apparatus | |
| US20210000355A1 (en) | Stress evaluation device, stress evaluation method, and non-transitory computer-readable medium | |
| CN101203175B (zh) | 用于缓解压力的方法和设备 | |
| US20200383636A1 (en) | System for Measuring Stress Level | |
| US11439347B2 (en) | Portable dehydration monitoring system | |
| Inna Khazan PhD | A guide to normal values for biofeedback | |
| Beauchamp | Thought Technology Ltd. | |
| FI20215427A1 (en) | System, method and computer program for monitoring a person's health | |
| WO2023078535A1 (en) | System and method for monitoring a physiological state of a user and providing at least one personalized breathing exercise to the user, and virtual monitoring program for executing the method | |
| Sakaguchi et al. | Control of heart rate variability by cardiac |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |